Literature DB >> 9032261

Lck regulates Vav activation of members of the Rho family of GTPases.

J Han1, B Das, W Wei, L Van Aelst, R D Mosteller, R Khosravi-Far, J K Westwick, C J Der, D Broek.   

Abstract

Vav is a member of a family of oncogene proteins that share an approximately 250-amino-acid motif called a Dbl homology domain. Paradoxically, Dbl itself and other proteins containing a Dbl domain catalyze GTP-GDP exchange for Rho family proteins, whereas Vav has been reported to catalyze GTP-GDP exchange for Ras proteins. We present Saccharomyces cerevisiae genetic data, in vitro biochemical data, and animal cell biological data indicating that Vav is a guanine nucleotide exchange factor for Rho-related proteins, but in similar genetic and biochemical experiments we fail to find evidence that Vav is a guanine nucleotide exchange factor for Ras. Further, we present data indicating that the Lck kinase activates the guanine nucleotide exchange factor and transforming activity of Vav.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032261      PMCID: PMC231859          DOI: 10.1128/MCB.17.3.1346

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA.

Authors:  J D Marth; R Peet; E G Krebs; R M Perlmutter
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

2.  Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation.

Authors:  M Tanaka; W Herr
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

3.  Amino acid residues in the CDC25 guanine nucleotide exchange factor critical for interaction with Ras.

Authors:  W Park; R D Mosteller; D Broek
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

4.  Molecular cloning of chromosome I DNA from Saccharomyces cerevisiae: isolation and characterization of the CDC24 gene and adjacent regions of the chromosome.

Authors:  K G Coleman; H Y Steensma; D B Kaback; J R Pringle
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

5.  Guanine nucleotide activation of, and competition between, RAS proteins from Saccharomyces cerevisiae.

Authors:  J Field; D Broek; T Kataoka; M Wigler
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Multicopy suppression of the cdc24 budding defect in yeast by CDC42 and three newly identified genes including the ras-related gene RSR1.

Authors:  A Bender; J R Pringle
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  The adenylyl cyclase gene from Schizosaccharomyces pombe.

Authors:  D Young; M Riggs; J Field; A Vojtek; D Broek; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells.

Authors:  S Katzav; D Martin-Zanca; M Barbacid
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

10.  Molecular characterization of CDC42, a Saccharomyces cerevisiae gene involved in the development of cell polarity.

Authors:  D I Johnson; J R Pringle
Journal:  J Cell Biol       Date:  1990-07       Impact factor: 10.539

View more
  76 in total

Review 1.  Regulatory and signaling properties of the Vav family.

Authors:  X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways.

Authors:  P S Costello; A E Walters; P J Mee; M Turner; L F Reynolds; A Prisco; N Sarner; R Zamoyska; V L Tybulewicz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes.

Authors:  G M Doody; D D Billadeau; E Clayton; A Hutchings; R Berland; S McAdam; P J Leibson; M Turner
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

4.  Critical but distinct roles for the pleckstrin homology and cysteine-rich domains as positive modulators of Vav2 signaling and transformation.

Authors:  Michelle A Booden; Sharon L Campbell; Channing J Der
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.

Authors:  B P Liu; K Burridge
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  Intersectin 1L guanine nucleotide exchange activity is regulated by adjacent src homology 3 domains that are also involved in endocytosis.

Authors:  Jennifer L Zamanian; Regis B Kelly
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

7.  Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.

Authors:  Galit Lazer; Liron Pe'er; Marganit Farago; Kazuya Machida; Bruce J Mayer; Shulamit Katzav
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

8.  Vav family proteins couple to diverse cell surface receptors.

Authors:  S L Moores; L M Selfors; J Fredericks; T Breit; K Fujikawa; F W Alt; J S Brugge; W Swat
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

9.  G protein beta gamma subunit-dependent Rac-guanine nucleotide exchange activity of Ras-GRF1/CDC25(Mm).

Authors:  M Kiyono; T Satoh; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

10.  Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.

Authors:  L Zeng; P Sachdev; L Yan; J L Chan; T Trenkle; M McClelland; J Welsh; L H Wang
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.